Long QT syndrome
Tirzepatide, a dual glucagon-like peptide-1 (GIP) and GLP-1RAs, administered once weekly at a 15 mg dose, resulted in an average weight loss of 20.9% over 72 weeks (Jastreboff et al., 2022), driven by its synergistic effects on appetite regulation, energy intake reduction, and fat mass decrease (Heise et al., 2023)
Lipid peroxidation scavengers/chain reaction blockers act as radical-trapping antioxidants (RTAs), interrupting the chain amplification of lipid peroxidation and protecting membrane phospholipids, particularly PUFA-containing phospholipids, from oxidative damage
[19] [20] Medication adherence and injection technique also matter
Glutathione is a tripeptide, which is a fancy way of saying it is a small protein made of three amino acids: glutamine, glycine, and cysteine
Novo Nordisk, which is a well-known health company, makes all three